References in periodicals archive ?
Bioenvision's European development program for clofarabine is on target with pivotal, Phase II, multi-centre studies ongoing in both pediatric and adult acute leukemias.
for the development and supply of clofarabine, Bioenvision's lead drug for the treatment of pediatric and adult acute leukemias.